135 related articles for article (PubMed ID: 2079426)
21. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.
Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
Ann Neurol; 1994 Aug; 36(2):166-75. PubMed ID: 8053652
[TBL] [Abstract][Full Text] [Related]
22. A computed tomography study of Alzheimer's disease.
Arai H; Kobayashi K; Ikeda K; Nagao Y; Ogihara R; Kosaka K
J Neurol; 1983; 229(2):69-77. PubMed ID: 6191001
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia.
Duara R; Barker W; Loewenstein D; Pascal S; Bowen B
Eur Neurol; 1989; 29 Suppl 3():9-15. PubMed ID: 2612532
[TBL] [Abstract][Full Text] [Related]
24. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy.
Ibáñez V; Pietrini P; Furey ML; Alexander GE; Millet P; Bokde AL; Teichberg D; Schapiro MB; Horwitz B; Rapoport SI
Brain Res Bull; 2004 Mar; 63(2):147-54. PubMed ID: 15130704
[TBL] [Abstract][Full Text] [Related]
25. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Kuhl DE; Metter EJ; Riege WH
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
[TBL] [Abstract][Full Text] [Related]
26. [Positron emission tomographic studies using C-11-glucose in normal aging and cerebrovascular dementia].
Ujike T; Terashi A; Soeda T; Kitamura S; Kato T; Iio M
No To Shinkei; 1984 Jun; 36(6):559-66. PubMed ID: 6331840
[TBL] [Abstract][Full Text] [Related]
27. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomographic studies of aging and Alzheimer disease.
de Leon MJ; Ferris SH; George AE; Christman DR; Fowler JS; Gentes C; Reisberg B; Gee B; Emmerich M; Yonekura Y; Brodie J; Kricheff II; Wolf AP
AJNR Am J Neuroradiol; 1983; 4(3):568-71. PubMed ID: 6410799
[TBL] [Abstract][Full Text] [Related]
29. Computed tomography findings in senile dementia and normal aging.
Soininen H; Puranen M; Riekkinen PJ
J Neurol Neurosurg Psychiatry; 1982 Jan; 45(1):50-4. PubMed ID: 7062070
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
31. Quantitative indexes of computed tomography in dementia and normal aging.
Brinkman SD; Sarwar M; Levin HS; Morris HH
Radiology; 1981 Jan; 138(1):89-92. PubMed ID: 7455102
[TBL] [Abstract][Full Text] [Related]
32. Multi-infarct dementia: a computed tomographic study.
Jayakumar PN; Taly AB; Shanmugam V; Nagaraja D; Arya BY
Acta Neurol Scand; 1989 Apr; 79(4):292-5. PubMed ID: 2728852
[TBL] [Abstract][Full Text] [Related]
33. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
Ng SY; Villemagne VL; Masters CL; Rowe CC
Arch Neurol; 2007 Aug; 64(8):1140-4. PubMed ID: 17698704
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
[TBL] [Abstract][Full Text] [Related]
35. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
[TBL] [Abstract][Full Text] [Related]
36. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging.
Kobari M; Meyer JS; Ichijo M
Arch Neurol; 1990 Feb; 47(2):161-5. PubMed ID: 2302088
[TBL] [Abstract][Full Text] [Related]
37. Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography.
Rosenthal G; Gilman S; Koeppe RA; Kluin KJ; Markel DS; Junck L; Gebarski SS
Ann Neurol; 1988 Sep; 24(3):414-9. PubMed ID: 3265863
[TBL] [Abstract][Full Text] [Related]
38. Quantitative computed tomography in dementia of the Alzheimer type.
Creasey H; Schwartz M; Frederickson H; Haxby JV; Rapoport SI
Neurology; 1986 Dec; 36(12):1563-8. PubMed ID: 3785670
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography in aging and senile dementia of the Alzheimer type.
de Leon MJ; George AE
Adv Neurol; 1983; 38():103-22. PubMed ID: 6604399
[No Abstract] [Full Text] [Related]
40. Positron emission tomography in the differential diagnosis of organic dementias.
Heiss WD; Kessler J; Szelies B; Grond M; Fink G; Herholz K
J Neural Transm Suppl; 1991; 33():13-9. PubMed ID: 1753242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
